AstraZeneca’s recent fallout places Pfizer in a leading position to monetize and manipulate the ongoing Covid-19 Vaccine Wars. Pfizer CFO Frank D’Amelio recently stated the obvious concerning the Covid-19 Vaccine market, “If you look at how current demand and current pricing is being driven, it’s clearly not being driven by what I’ll call normal market conditions or normal market forces… it’s been driven by the pandemic state we’ve been in, and the needs of governments to secure doses from various vaccine suppliers.”
D’ Amelio’s highly polished statement in a Business Insider France article can be more accurately paraphrased as, “Our current Covid-19 vaccine market forces are driven by profit, emotional pandering, histrionic threats, and fear.”
While AstraZeneca reels over multiple bans in the EU and suspensions of their vaccine, which has caused multiple deaths and horrific side effects, Pfizer has primed itself to capitalize. Pfizer will not only capitalize from the stagnation of a significant pharma competitor, it has developed another emerging fear tactic to boost sales.
“Two shots aren’t enough to protect you from Covid-19!” Pfizer CEO Albert Bourla stated “the hope is that a third dose will boost the immune response even higher, offering better protection against variants” during a recent interview with NBC news.
If everything goes well in the Pfizer plan, you will need three Covid-19 vaccine rounds, as well as an annual booster, to protect yourself from Covid-19 and it’s variants.